Skip to content

Comparison of Pain score and Treatment effect between Bolus infusion method and Continuous infusion method when Hypertonic saline infusion in epidural adhesiolysis

Comparison of Pain score and Treatment effect between Bolus infusion method and Continuous infusion method when Hypertonic saline infusion in epidural adhesiolysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003321
Enrollment
50
Registered
2018-11-05
Start date
2017-10-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : After performing lumbar epidural adhesiolysis, 6 mL of 10&#37
NaCl solution was injected through epidural catheter by the following method. In the bolus group, 1.5 ml of 10&#37
hypertonic saline was injected slowly through epidural catheter four times every 15 minutes. 1.5 ml of hypertonic saline was administered slowly over 5 - 10 seconds. In the continuous infusion group,
hypertonic saline was continuously infused for 60 minutes through an infusion pump connected to the epidural catheter.

Sponsors

Seoul National University Bundang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients between 18 and 80 years of age; (2) patients with a history of chronic low back pain and/or lower extremity radiating pain of at least 6 months; (3) patients who received lumbar epidural adhesiolysis with a 1-day protocol including hypertonic saline infusion; (4) patients with numerical rating scale (NRS) pain scores of 6 or more after appropriate conservative treatments, such as oral analgesics, physical therapy and epidural steroid injection.

Exclusion criteria

Exclusion criteria: (1) complaints of back pain more severe than leg pain; (2) lack of correlation between neuropathic back pain with radicular symptoms and MRI findings; (3) lumbar surgical intervention in previous 6 months; (4) coagulopathy, chronic infection or skin infection at the procedure site; (5) poorly controlled psychiatric disorders or acute medical illness, underlying systemic diseases that could interfere with the interpretation of the outcome assessments; (6) pregnant or lactating women; (7) with a history of adverse reaction to local anesthetics or steroids; (8) patients who require other interventions with uncontrolled pain during the follow-up period; (9) patients unable to understand the informed consent and protocol and (10) patients unable to be positioned in prone position to perform the procedure.

Design outcomes

Primary

MeasureTime frame
The difference in changes in the 11-point NRS scores (0 = no pain, 10 = unbearable pain) induced by hypertonic saline infusion between patients in the 2 groups.

Secondary

MeasureTime frame
The difference in changes in the 11-point NRS scores (0 = no pain, 10 = unbearable pain) of low back and/or lower extremity pain between patients in the 2 groups.;The difference in changes in the ODI between patients in the 2 groups.

Countries

Korea, Republic of

Contacts

Public ContactPyung-Bok LEE

Seoul National University Bundang Hospital

painfree@snubh.org+82-31-787-7495

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026